Zobrazeno 1 - 6
of 6
pro vyhledávání: '"M Antonia Alvarez-Lara"'
Autor:
Cristian Rodelo-Haad, Maria E Rodríguez-Ortiz, Alejandro Martin-Malo, M Victoria Pendon-Ruiz de Mier, M Luisa Agüera, Juan R Muñoz-Castañeda, Sagrario Soriano, Francisco Caravaca, M Antonia Alvarez-Lara, Arnold Felsenfeld, Pedro Aljama, Mariano Rodriguez
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0201537 (2018)
BACKGROUND:In hemodialysis patients, high levels of Fibroblast Growth Factor 23 (FGF23) predict mortality. Our study was designed to test whether the control of serum phosphate is associated with a reduction in serum FGF23 levels. Additionally other
Externí odkaz:
https://doaj.org/article/559ce5f86f0c4e4d8e5b0bcbc9f0c064
Autor:
Alejandro Martin-Malo, Pedro Aljama, Javier Caballero-Villarraso, M. Victoria Pendón-Ruiz de Mier, Corona Alonso, Sagrario Soriano, Ana Navas, Mariano Rodriguez, Raquel Ojeda, Miguel A. Alvarez, M. Antonia Alvarez-Lara
Publikováno v:
BMC Nephrology
BMC Nephrology, Vol 21, Iss 1, Pp 1-8 (2020)
BMC Nephrology, Vol 21, Iss 1, Pp 1-8 (2020)
Background Acute kidney injury (AKI) occurs in 12–20% of multiple myeloma (MM) patients. Several studies have shown a reduction of free light chains (FLC) using hemodialysis with High-Cut-Off membranes. However, this technique entails albumin loss.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05485cb4149c970fb111ff8b138870f1
https://doi.org/10.21203/rs.2.22309/v1
https://doi.org/10.21203/rs.2.22309/v1
Autor:
Juan R. Muñoz-Castañeda, M. Antonia Alvarez-Lara, María E. Rodríguez-Ortiz, Alejandro Martin-Malo, M. Victoria Pendón-Ruiz de Mier, Pedro Aljama, M. Luisa Agüera, Mariano Rodriguez, Francisco Caravaca, Cristian Rodelo-Haad, Arnold J. Felsenfeld, Sagrario Soriano
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
PLoS ONE
PLoS ONE, Vol 13, Iss 8, p e0201537 (2018)
Consejería de Sanidad de la Comunidad de Madrid
PLoS ONE
PLoS ONE, Vol 13, Iss 8, p e0201537 (2018)
BACKGROUND:In hemodialysis patients, high levels of Fibroblast Growth Factor 23 (FGF23) predict mortality. Our study was designed to test whether the control of serum phosphate is associated with a reduction in serum FGF23 levels. Additionally other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41a5fceca42eb202da2170bd6d4fd261
https://repositoriosaludmadrid.es/handle/20.500.12530/35924
https://repositoriosaludmadrid.es/handle/20.500.12530/35924
Autor:
Mariano Rodriguez, Pedro Aljama, Alberto Rodríguez-Benot, Alejandro Martin-Malo, M. Antonia Alvarez-Lara
Publikováno v:
American Journal of Kidney Diseases. 46:68-77
Severe hyperphosphatemia (serum phosphate level6.5 mg/dL [2.10 mmol/L]) has been associated directly with increased overall and cardiovascular mortality in hemodialysis (HD) patients. Currently, clinical guidelines recommend maintaining phosphate lev
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.